The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world analysis of efficacy and safety of biweekly gemcitabine and docetaxel (GEMDOC) in heavily pretreated metastatic castration-resistant prostate cancer.
 
Jordan Ciuro
No Relationships to Disclose
 
Ahmet Yildirim
No Relationships to Disclose
 
Angelo Marra
No Relationships to Disclose
 
Yuan Liu
No Relationships to Disclose
 
Bassel Nazha
Honoraria - Intellisphere, LLC (Onclive)
Consulting or Advisory Role - Cardinal Health; Exelixis; IntrinsiQ; NeoGenomics Laboratories
 
Mehmet Bilen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Exelixis; Genomic Health; Janssen; Nektar; Pfizer; Sanofi; SeaGen
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genome & Company (Inst); Incyte (Inst); Merck (Inst); Nektar (Inst); NiKang Therapeutics (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst); Xencor (Inst)
 
Jacqueline Brown
Honoraria - DAVA Oncology
Consulting or Advisory Role - AstraZeneca; AstraZeneca; EMD Serono; Exelixis; Pfizer; Xencor
Research Funding - Duality Biologics; Hookipa Pharma (Inst); Macrogenics; Medicenna (Inst); Merck (Inst); Pliant; Surface Oncology (Inst); Xencor (Inst)
 
Bradley Carthon
No Relationships to Disclose
 
Jacob Berchuck
Stock and Other Ownership Interests - Cityblock Health (I); Genome Medical; Musculo; Oncotect; Precede Bio; TracerDx
Honoraria - Guardant Health
Consulting or Advisory Role - Genome Medical; Guardant Health; Musculo; Oncotect; Precede Bio; TracerDx
Speakers' Bureau - Guardant Health
Research Funding - Guardant Health (Inst); Precede Bio (Inst)
Patents, Royalties, Other Intellectual Property - Institutional patent filed on methods for detecting prostate cancer resistance using cell-free DNA
Travel, Accommodations, Expenses - Guardant Health
 
Shahid Ahmed
No Relationships to Disclose
 
Ravi Parikh
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; GNS Healthcare; Main Street Health; Mendel.ai; Merck; Onc.AI; Thyme Care
Honoraria - Wake Forest School of Medicine
Consulting or Advisory Role - Archetype Therapeutics; Biofourmis; ConcertAI; Credit Suisse; G1 Therapeutics; Humana; Klick Inc; Main Street Health; Mendel AI; Merck; Onc.ai; Thyme Care
Research Funding - Arnold Ventures (Inst); Commonwealth Fund (Inst); Emerson Collective (Inst); Mendel AI (Inst); Prostate Cancer Foundation (Inst); Schmidt Futures (Inst)
Patents, Royalties, Other Intellectual Property - Technology to integrate patient-reported outcomes into electronic health record algorithms
 
Omer Kucuk
No Relationships to Disclose